Panagora Asset Management’s Sage Therapeutics SAGE Stock Holding History

Panagora Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,477	Closed	-$84K	–	2275
2021 Q2	$84K	Sell	1,477 -122	-8%	-$8.62K	﹤0.01%	1950
2021 Q1	$120K	Buy	1,599 +1,374	+611%	+$113K	﹤0.01%	1905
2020 Q4	$19K	Sell	225 -236	-51%	-$17.4K	﹤0.01%	2198
2020 Q3	$28K	Sell	461 -111	-19%	-$5.63K	﹤0.01%	2131
2020 Q2	$24K	Buy	572 +218	+62%	+$7.91K	﹤0.01%	2109
2020 Q1	$10K	Buy	354 +68	+24%	+$3.94K	﹤0.01%	2138
2019 Q4	$21K	Buy	+286	New	+$35.2K	﹤0.01%	2034
2018 Q2	–	Sell	-3,567	Closed	-$575K	–	2411
2018 Q1	$575K	Buy	+3,567	New	+$606K	﹤0.01%	1340
2016 Q1	–	Sell	-378	Closed	-$22K	–	2335
2015 Q4	$22K	Sell	378 -636	-63%	-$31.5K	﹤0.01%	2132
2015 Q3	$43K	Sell	1,014 -239	-19%	-$14.7K	﹤0.01%	2030
2015 Q2	$91K	Buy	+1,253	New	+$80.6K	﹤0.01%	1978

Other funds holding SAGE

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Panagora Asset Management's SAGE Position: Q3 2021 in Review

Panagora Asset Management sold out of Sage Therapeutics (SAGE) in Q3 2021, closing a stake of 1,477 shares — an estimated $84K sold.

Panagora Asset Management first reported a position in SAGE in Q2 2015 and held it in 11 quarters. The position peaked at $575K in Q1 2018. 226 funds tracked by Wall St. Rank hold SAGE as of Q3 2021.

Panagora Asset Management reported no remaining Sage Therapeutics position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 1,477 Sage Therapeutics shares in Q3 2021, an estimated $84K.
Panagora Asset Management first reported a position in Sage Therapeutics in Q2 2015 and held it in 11 quarters.
Panagora Asset Management's Sage Therapeutics position peaked at $575K in Q1 2018.
226 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.